BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34269944)

  • 21. Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.
    Minashi K; Nihei K; Mizusawa J; Takizawa K; Yano T; Ezoe Y; Tsuchida T; Ono H; Iizuka T; Hanaoka N; Oda I; Morita Y; Tajika M; Fujiwara J; Yamamoto Y; Katada C; Hori S; Doyama H; Oyama T; Nebiki H; Amagai K; Kubota Y; Nishimura K; Kobayashi N; Suzuki T; Hirasawa K; Takeuchi T; Fukuda H; Muto M
    Gastroenterology; 2019 Aug; 157(2):382-390.e3. PubMed ID: 31014996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASO Author Reflections: Additional Esophagectomy After Noncurative Endoscopic Resection Versus Upfront Esophagectomy in Patients with T1N0 Esophageal Squamous Cell Carcinoma.
    Maruyama S; Okamura A; Watanabe M
    Ann Surg Oncol; 2021 Sep; 28(9):4867-4868. PubMed ID: 33492541
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
    Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
    J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implication of endoscopic gross appearance in superficial esophageal squamous carcinoma: revisited.
    Huh CW; Jung DH; Kim JH; Ma DW; Youn YH; Park H
    Surg Endosc; 2018 Jan; 32(1):367-375. PubMed ID: 28664436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort.
    Zhang Y; Ding H; Chen T; Zhang X; Chen WF; Li Q; Yao L; Korrapati P; Jin XJ; Zhang YX; Xu MD; Zhou PH
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):73-81.e3. PubMed ID: 29704682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curative Management After Endoscopic Resection for Esophageal Squamous Cell Carcinoma Invading Muscularis Mucosa or Shallow Submucosal Layer-Multicenter Real-World Survey in Japan.
    Katada C; Yokoyama T; Hirasawa D; Iizuka T; Kikuchi D; Yano T; Hombu T; Yoshio T; Yoshimizu S; Ono H; Yabuuchi Y; Terai S; Hashimoto S; Takahashi K; Tanaka S; Urabe Y; Arima M; Tanabe S; Wada T; Furue Y; Oyama T; Takahashi A; Sakamoto Y; Muto M
    Am J Gastroenterol; 2023 Jul; 118(7):1175-1183. PubMed ID: 36624037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASO Author Reflections: Esophagectomy or Chemoradiotherapy, That is the Question: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma.
    Kanie Y; Okamura A; Asari T; Ishiyama A; Yoshio T; Tsuchida T; Chin K; Watanabe M
    Ann Surg Oncol; 2021 Dec; 28(13):8436-8437. PubMed ID: 34115253
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: Is Esophagectomy Necessary after Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma?
    Liu Z; Zhao J; Li Z
    Ann Surg Oncol; 2021 Nov; 28(12):7160-7161. PubMed ID: 34263374
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparison.
    Plum PS; Hölscher AH; Pacheco Godoy K; Schmidt H; Berlth F; Chon SH; Alakus H; Bollschweiler E
    Surg Endosc; 2018 Sep; 32(9):3972-3980. PubMed ID: 29536160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of lymph node metastasis and residual tumor in early gastric cancer patients after noncurative endoscopic resection: a systematic review and meta-analysis.
    Jiang B; Zhou L; Lu J; Wang Y; Guo J
    Therap Adv Gastroenterol; 2020; 13():1756284820935033. PubMed ID: 32636929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.
    Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Ohira M
    Esophagus; 2019 Apr; 16(2):147-154. PubMed ID: 30311102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis.
    Jiang KY; Huang H; Chen WY; Yan HJ; Wei ZT; Wang XW; Li HX; Zheng XY; Tian D
    World J Gastroenterol; 2021 Feb; 27(8):737-750. PubMed ID: 33716451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.
    Okamura A; Watanabe M; Mine S; Kurogochi T; Yamashita K; Hayami M; Imamura Y; Ogura M; Ichimura T; Takahari D; Chin K
    Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similar survival after endoscopic submucosal dissection and esophagectomy in early esophageal cancer and synchronous or metachronous head and neck cancer.
    Ke RT; Hsiao YH; Tai WC; Li SH; Yao CC; Chuang KH; Lai HH; Chen Y; Chen LC; Lu HI; Chen YH; Lo CM
    J Cardiothorac Surg; 2024 Feb; 19(1):52. PubMed ID: 38311758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of endoscopic resection in superficial esophageal squamous carcinoma.
    Choi JY; Park YS; Jung HY; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Lee GH; Cho KJ; Kim JH
    Gastrointest Endosc; 2011 May; 73(5):881-9, 889.e1-2. PubMed ID: 21392755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management decision based on lymphovascular involvement leads to favorable outcomes after endoscopic treatment of esophageal squamous cell carcinoma.
    Takahashi K; Hashimoto S; Mizuno KI; Kobayashi T; Tominaga K; Sato H; Kohisa J; Ikarashi S; Hayashi K; Takeuchi M; Yokoyama J; Kawai H; Sato Y; Kobayashi M; Terai S
    Endoscopy; 2018 Jul; 50(7):662-670. PubMed ID: 29272907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
    Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
    Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphovascular invasion as an independent prognostic indicator in radically resected thoracic esophageal squamous cell carcinoma.
    Wang Z; Chen P; Wang F; Lin L; Liu S
    Thorac Cancer; 2019 Feb; 10(2):150-155. PubMed ID: 30484962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of technical difficulty during endoscopic submucosal dissection of superficial esophageal cancer.
    Hazama H; Tanaka M; Kakushima N; Yabuuchi Y; Yoshida M; Kawata N; Takizawa K; Ito S; Imai K; Hotta K; Ishiwatari H; Matsubayashi H; Mori K; Ono H
    Surg Endosc; 2019 Sep; 33(9):2909-2915. PubMed ID: 30478695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.